2025-07-23 - Analysis Report
Okay, here's an analysis of Transmedics Group Inc (TMDX) based on the provided data, formatted as a report in English with a focus on key metrics and insights.

## Transmedics Group Inc (TMDX) Analysis

**Company Overview:** Transmedics Group Inc. is a medical technology company focused on developing and delivering innovative organ preservation systems for transplantation therapy.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (TMDX):** 224.69%
*   **Cumulative Return (VOO):** 68.64%
*   **Absolute Spread:** 154.05%
*   **Relative Spread Position:** 60.6 (Indicates TMDX's outperformance is in the 61st percentile of its historical range vs. VOO)

**Analysis:** TMDX has significantly outperformed the S&P 500. The current spread of 154.05% indicates substantial outperformance.  However, a relative spread position of 60.6 suggests that while the outperformance is strong, it is not at the extreme upper end of its historical range.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD     | Alpha  | Beta  | Cap(B) |
| ---------- | ------ | ------- | ------ | ----- | ------ |
| 2019-2021  | -4.0%  | 63.4%   | -52.0% | 0.0   | 0.7   |
| 2020-2022  | 140.0% | 68.3%   | 138.0% | 0.1   | 2.1   |
| 2021-2023  | 95.0%  | 69.4%   | 77.0%  | 0.2   | 2.7   |
| 2022-2024  | 147.0% | 82.8%   | 121.0% | 0.2   | 2.1   |
| 2023-2025  | 106.0% | 82.8%   | 57.0%  | 0.5   | 3.6   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate (CAGR) shows very high growth recently.
*   **MDD:** The Maximum Drawdown (MDD) is relatively high, suggesting significant volatility.
*   **Alpha:**  The Alpha is consistently positive, indicating outperformance relative to the market (S&P 500). Note the early period with negative alpha.
*   **Beta:** The Beta is low, but has been increasing. This implies the stock is becoming increasingly correlated to the market.
*   **Cap:** Market Cap has significantly grown, showing increased investor confidence.

### 2. Recent Price Action

*   **Current Price:** 105.60
*   **Previous Close:** 103.61
*   **Change:** +1.92
*   **5-Day Moving Average:** 108.99
*   **20-Day Moving Average:** 121.78
*   **60-Day Moving Average:** 120.40

**Analysis:**

The price increased compared to the previous close, but is currently below the 5, 20 and 60 day moving averages, suggesting a recent downtrend.  The positive change relative to the previous close is a rebound sign, but the moving averages suggest it may be a temporary bump in a downtrend.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 21.39 (Oversold)
*   **PPO:** -2.07 (Bearish)
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35) (Cash Ratio: 69% on 2025-06-16)
*   **20-Day Relative Spread Change:** -3.2 (Negative, indicating recent underperformance vs. VOO)
*   **Expected Return:** 62.6% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates Low Risk.
*   The RSI suggests the stock is oversold, which could signal a potential rebound.
*   The PPO is negative, indicating bearish momentum.
*   The Hybrid Signal advises a small reduction in holdings and highlights a cautious stance, which aligns with the downtrend from the moving average information.
*   The negative change in the relative spread confirms recent underperformance.
*   Despite the recent downturn, the expected return remains high, suggesting optimism for long-term investors. The current price bump should be considered due to the large change from the previous close.

### 4. Recent News & Significant Events

*   **[2025-07-22]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-21]:** Analyst discussions on recent performance and outlook.
*   **[2025-07-23]:** Notable stock volatility.
*   **[2025-07-19]:** Market experts highlight both risks and opportunities.

**Analysis:**  Recent news suggests the company is experiencing a period of significant activity and scrutiny.  Volatility is present, and analysts are actively evaluating the company's prospects. Investors should closely monitor these developments.

### 5. Recent Earnings Analysis

| Date       | EPS  | Expected EPS |
| ---------- | ---- | ------------ |
| 2025-05-08 | 0.70 | 0.29         |
| 2025-02-27 | 0.19 | 0.22         |
| 2024-10-28 | 0.12 | 0.29         |
| 2024-07-31 | 0.35 | 0.21         |
| 2024-04-30 | 0.35 | 0.03256      |

**Analysis:** Transmedics has recently delivered strong earnings beats, exceeding expectations in multiple quarters. The most recent quarter shows a significant outperformance, indicating positive business momentum. However, the period prior to the most recent earnings quarter was mixed (either meeting, or falling short of estimates).

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
| ---------- | ------- | ------------- |
| 2025-03-31 | $0.14B  | 61.47%        |
| 2024-12-31 | $0.12B  | 59.21%        |
| 2024-09-30 | $0.11B  | 55.94%        |
| 2024-06-30 | $0.11B  | 60.59%        |
| 2024-03-31 | $0.10B  | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE    |
| ---------- | ------- | ------ |
| 2025-03-31 | $0.27B  | 9.64%  |
| 2024-12-31 | $0.23B  | 3.00%  |
| 2024-09-30 | $0.21B  | 2.01%  |
| 2024-06-30 | $0.19B  | 6.42%  |
| 2024-03-31 | $0.16B  | 7.65%  |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing, indicating strong growth.
*   **Profit Margin:** Profit margins remain high, above 55%, showing efficient operations.
*   **Equity:** Equity has been consistently increasing.
*   **ROE:** The Return on Equity (ROE) is volatile, but the most recent quarter shows a significant improvement, suggesting a positive trend.

### 7. Overall Assessment

Transmedics Group Inc. (TMDX) exhibits strong long-term growth potential, evidenced by its significant outperformance compared to the S&P 500 and high expected return. Recent earnings beats and increasing revenue and equity further reinforce this positive outlook.

However, investors should be aware of the recent price volatility, bearish momentum indicated by technical indicators (PPO), and the hybrid signal suggesting caution. The recent downturn, as reflected in the moving averages and relative spread change, warrants careful monitoring. It is also important to be aware of the high historical MDD.

**Recommendation:**

Given the mixed signals, a cautious approach is advised. Investors should consider monitoring the stock closely, particularly in light of recent news and developments. It is also important to note that the recent price action indicates that the price is bumping after some drop.
